SCOPUS 정보 검색 플랫폼

Journal of Physiology Paris

Volumn 95, Issue 1-6, 2001, Pages 399-405

Therapy for chronic hepatitis C

(4) Pár, Alajos a,d Telegdy, László b Dalmi, Lajos c Müller, Eva b

a UNIVERSITY OF PÉCS (Hungary)

b Szent Laszlo Hospital (Hungary)

c Kenezy Hospital Ltd (Hungary)

d Tel: +36 72 536 000 ^* (Hungary)

Author keywords

Chronic hepatitis C; Hungary; Ribavirin; Treatment interferon

Indexed keywords

INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FIBROSIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; MALE; MIDDLE AGED; PROGNOSIS; RIBAVIRIN; RNA, VIRAL;

EID: 0034749916 PISSN: 09284257 EISSN: None Source Type: Journal
DOI: 10.1016/S0928-4257(01)00054-7 Document Type: Conference Paper

Times cited : (6)

References (42)

1
- 0002575528
- Hepatitis C: Diagnosis and therapy
- R. Schmid, L. Bianchi, H.L. Blum (Eds.), Kluwer Academic Publ, Dordrecht, Boston, London
- (1995) Acute and Chronic Hepatitis , pp. 67-83
- Alberti, A.¹ Chemello, L.² Pontisso, P.³ Cavaletto, L.⁴ Benvegnu, L.⁵ Bernardinello, E.⁶ De Salvo, G.L.⁷ Noventa, F.⁸

2
- 24044492056
- Long term effects of extended duration on interferon treatment for chronic hepatitis C
- Chicago, 8-12 November
- (1996) International Symposium on Hepatitis C held during the 47th Annual Meeting of the American Association for the Study of the Liver , pp. 8-12
- Alberti, A.¹

3
- 0031894550
- Hepatitis C
- (1998) Infect. Diseases Clinics of North Amer. , vol.12 , pp. 13-26
- Alter, M.J.¹ Mast, E.E.² Moyer, L.A.³ Margolis, H.S.⁴

4
- 0030955346
- Epidemiology of hepatitis C
- (1997) Hepatology , vol.26 , Issue.SUPPL. 1 , pp. 62-65
- Alter, M.J.¹

5
- 0034092720
- Pathogenesis, diagnosis and management of hepatitis C
- (2000) J. Hepatology , vol.32 , Issue.SUPPL. 1 , pp. 98-112
- Boyer, N.¹ Marcellin, P.²

6
- 0032904754
- Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha no-responders
- (1999) Ital. J. Gastroenterol. Hepatol. , vol.31 , pp. 130-134
- Brillanti, S.¹ Foli, M.² Di Tomasso, M.³ Gramantieri, L.⁴ Masci, C.⁵ Bolondi, L.⁶

7
- 0032560376
- Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study
- (1998) Lancet , vol.341 , pp. 1535-1539
- Brunetto, M.R.¹ Oliveri, F.² Koehler, M.³ Zahm, F.⁴ Bonino, F.⁵

8
- 0029156655
- Randomized trial comparing three different regimens of interferon alpha-2a in chronic hepatitis C
- (1995) Hepatology , vol.22 , pp. 700-706
- Chemello, L.¹ Bonetti, P.² Cavaletto, L.³ Talato, F.⁴ Donadon, V.⁵ Casarin, P.⁶ Belussi, F.⁷ Frezza, M.⁸ Noventa, F.⁹ Pontisso, P.¹⁰ Benvegnu, L.¹¹ Casarin, C.¹² Alberti, A.¹³

9
- 0030885469
- Factors predictive of beneficial response to therapy of hepatitis C
- (1997) Hepatology , vol.26
- Davis, G.L.¹ Lau, J.Y.N.²

10
- 0032547944
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
- (1998) New Eng. J. Med. , vol.339 , pp. 1493-1499
- Davis, G.L.¹ Esteban-Mur, R.² Rustgi, V.K.³ Hoefs, J.⁴ Gordon, S.C.⁵ Trep, C.⁶ Shiffman, M.L.⁷ Zeuzem, S.⁸ Craxi, A.⁹ Ling, M.-H.¹⁰ Albrecht, J.¹¹

11
- 0002553396
- A model to predict sustained response to therapy and to optimize the dose of interferon in chronic hepatitis C
- (1995) J. Hepatol. , vol.23 , pp. 93
- De Salvo, G.L.¹ Noventa, F.² Chemello, L.³ Casarin, C.⁴ Pontisso, P.⁵ Bonetti, P.⁶ Urso, M.⁷ Crisara, D.⁸ Alberti, A.⁹

12
- 0033054813
- EASL International Consensus Conference on Hepatitis C, Consensus statement
- (1999) J. Hepatol. , vol.30 , pp. 956-961

13
- 84889128800
- Preliminary clinical results of combination pegylated interferon alpha-2b+Ribavirin
- Rotterdam, The Netherlands, 1 May
- (2000) Satellite Symposium on Pegylated Interferon alpha 2b held during the 35th Annual Meeting of the European Association for the Study of the Liver , pp. 19-20
- Esteban-Mur, R.¹

14
- 0030563975
- Effect of interferon alpha-2b treatment in chronic hepatitis
- in Hungarian
- (1996) Orv. Hetil. , vol.137 , pp. 1179-1185
- Fehér, J.¹ Lengyel, G.²

15
- 0033406824
- Hepatitis C virus infection: Quality of life and side effects
- (1999) J. Hepatol. , vol.31 , Issue.SUPPL. 1 , pp. 250-254
- Foster, G.R.¹

16
- 4243339996
- A dose-ranging study of PEG-Intron and ribavirin in chronic hepatitis C - Safety, efficacy and virologic rationale
- (1999) Hepatology , vol.30
- Glue, P.¹ Sabo, R.² Rouzier-Panis, R.³ Gupta, S.K.⁴ Jacobs, S.⁵ Ingravallo, P.⁶

17
- 0031927737
- Clinical outcome of hepatitis C as a function of mode of transmission
- (1998) Hepatology , vol.28 , pp. 562-567
- Gordon, S.C.¹ Bayati, N.² Silverman, A.³

18
- 0002666682
- Hepatitis C virus
- (1999) Current Practice of Medicine , vol.2 , pp. 935-942
- Gordon, S.C.¹ Schiff, E.R.²

19
- 0031927053
- Therapy of viral hepatitis
- (1998) Digestion , vol.59 , pp. 563-578
- Hoofnagle, J.H.¹

20
- 0027416870
- Treatment of chronic hepatitis C with high-dose interferon alpha-2b
- (1993) Dig. Dis. Sci. , vol.38 , pp. 612-618
- Iino, S.¹ Hino, K.² Kuroki, T.³ Suzuki, H.⁴ Yamamoto, S.⁵

21
- 0031704927
- 10-Year follow-up after interferon alpha therapy for chronic hepatitis C
- (1998) Hepatology , vol.28 , pp. 1121-1127
- Lau, D.T.Y.¹ Kleiner, D.E.² Chang, M.G.³ Park, Y.⁴ Schmid, P.⁵ Hoofnagle, J.H.⁶

22
- 15644380122
- Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy
- (1997) Ann. Intern. Med. , vol.127 , pp. 875-881
- Marcellin, P.¹ Boyer, N.² Gervais, A.³ Martinot, M.⁴ Pouteau, M.⁵ Castelnau, C.⁶ Kilani, A.⁷ Areias, J.⁸ Auperin, A.⁹ Benhamou, J.P.¹⁰ Claude Degott, C.¹¹ Erlinger, S.¹²

23
- 0000102877
- Randomized controlled trial of combination therapy with interferon (IFN) alpha-2a and ribavirin in patients with chronic hepatitis C who relapsed after interferon therapy
- (1999) Hepatology , vol.30 , Issue.SUPPL. 2
- Marcellin, P.¹ Hezode, C.² Castelnau, C.³ Barange, K.⁴ Couzigou, P.⁵ Larrey, D.⁶

24
- 0032146432
- Predictors of sustained response to alpha interferon therapy in chronic hepatitis C
- (1998) J. Hepatol. , vol.29 , pp. 214-223
- Martinot-Peignoux, M.¹ Boyer, N.² Pouteau, M.³ Castelnau, C.⁴ Giuily, N.⁵ Duchatelle, V.⁶ Aupérin, A.⁷ Degott, C.⁸ Benhamou, J.P.⁹ Erlinger, S.¹⁰ Marcellin, P.¹¹

25
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) New Eng. J. Med. , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffmann, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶ Goodman, Z.D.⁷ Ling, M.-H.⁸ Cort, S.⁹ Albrecht, J.K.¹⁰

26
- 0030458737
- Treatment of chronic hepatitis C with alpha-interferon
- (1996) Hepato-Gastroenterol. , vol.43 , pp. 1544-1556
- Niederau, C.¹ Heintges, T.² Haussinger, D.³

27
- 17344370538
- Prognosis of chronic hepatitis C. Results of a large prospective cohort study
- (1998) Hepatology , vol.28 , pp. 1687-1695
- Niederau, C.¹ Lange, S.² Heintges, T.³ Erhardt, A.⁴ Buschkamp, M.⁵ Hurter, D.⁶ Nawrocki, M.⁷

28
- 0028876371
- Randomized trial of effects of interferon alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C
- (1995) Lancet , vol.346 , pp. 1051-1055
- Nishiguchi, S.¹ Kuroki, T.² Nakatani, S.³ Morimoto, H.⁴ Takeda, T.⁵ Nakajima, S.⁶ Shiomi, S.⁷ Seki, S.⁸ Kobayashi, K.⁹ Otani, S.¹⁰

29
- 84889109124
- Management of chronic hepatitis C
- in Hungarian
- (1993) Transzfuzió , vol.26 , pp. 75-85
- Pár, A.¹

30
- 0031773410
- Hepatitis C virus infection: Pathogenesis, diagnosis and treatment
- (1998) Scand. J. Gastroenterol. , vol.33 , Issue.SUPPL. 228 , pp. 107-114
- Pár, A.¹ Gervain, J.² Gógl, Á.³

31
- 0032421812
- Role of viral and host factors in the pathogenesis of hepatitis C virus infection and in the response to interferon treatment
- (1998) Period. Biol. , vol.100 , pp. 515-519
- Pár, A.¹ Paál, M.² Horányi, M.³ Pár, G.⁴ Szekeres-Bartho, J.⁵ Hegedüs, G.⁶ Gasztonyi, B.⁷ Mózsik, Gy.⁸

32
- 0029054011
- A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B
- (1995) New Engl. J. Med. , vol.332 , pp. 1457-1462
- Poynard, T.¹ Bedossa, P.² Chevallier, M.³ Mathurin, P.⁴ Lemonnier, C.⁵ Trepo, C.⁶ Couzigou, P.⁷ Payen, J.L.⁸ Sajus, M.⁹ Costa, J.M.¹⁰ Vidaud, M.¹¹ Chaput, J.C.¹²

33
- 0032585237
- Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.S.⁵ Ideo, G.⁶ Bain, V.⁷ Heathcote, J.⁸ Zeuzem, S.⁹ Trepo, C.¹⁰ Albrecht, J.¹¹

34
- 0032501714
- Randomized double blind, placebo controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C
- (1998) Lancet , vol.351 , pp. 83-87
- Reichard, O.¹ Norkrans, G.² Fryden, A.³ Braconier, J.-H.⁴ Sonnerborg, A.⁵ Weiland, O.⁶

35
- 0029589231
- Combination treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience
- (1995) J. Hepatol. , vol.23 , Issue.SUPPL. 2 , pp. 17-21
- Schvarcz, R.¹ Ando, Y.² Sönnerborg, A.³ Weiland, O.⁴

36
- 0000211888
- A controlled, randomized, multicenter descending dose phase II trial of pegylated interferon alpha-2A (PEG) vs standard interferon alpha 2A (IFN) for treatment of chronic hepatitis C
- (1999) Gastroenterology , vol.116
- Shiffman, M.L.¹ Pockros, P.J.² Reddy, R.K.³ Wright, T.L.⁴ Reindollar, R.⁵ Clin, C.⁶

37
- 0033429408
- Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C
- (1999) J. Hepatol. , vol.31 , Issue.SUPPL. 1 , pp. 152-159
- Thomas, H.C.¹ Torok, M.E.² Forton, D.M.³ Taylor-Robinson, S.D.⁴

38
- 0028998145
- Clinical outcomes after transfusion associated hepatitis
- (1995) New Engl. J. Med. , vol.332 , pp. 1463-1466
- Tong, M.D.¹ El-Fara, N.S.² Reikes, A.R.³ Co, R.L.⁴

39
- 0033405929
- Treatment of naive patients with chronic hepatitis C
- (1999) J. Hepatol. , vol.31 , Issue.SUPPL. 1 , pp. 168-173
- Weiland, O.¹

40
- 0000494074
- (1997) Weekly Epidemiological Record , vol.72 , pp. 65-72

41
- 0033520109
- Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and non-cirrhotic patients with chronic hepatitis C in Japan
- (1999) Ann. Intern. Med. , vol.131 , pp. 174-181
- Yoshida, H.¹ Shiratory, Y.² Moriyama, M.³ Arakawa, Y.⁴ Ideo, T.⁵ Sata, M.⁶

42
- 0030587906
- Hepatitis C virus genotypes in the US: Epidemiology, pathogenicity and response to interferon therapy
- (1996) Ann. Intern. Med. , vol.125 , pp. 634-639
- Zein, N.N.¹ Rakel, J.² Krawitt, E.L.³ Reddy, K.R.⁴ Tominaga, T.⁵ Persing, D.H.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.